These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 22487925)

  • 21. AAV8-mediated gene transfer of interleukin-4 to endogenous beta-cells prevents the onset of diabetes in NOD mice.
    Rehman KK; Trucco M; Wang Z; Xiao X; Robbins PD
    Mol Ther; 2008 Aug; 16(8):1409-16. PubMed ID: 18560422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of a germ-free environment on gut immune regulation and diabetes progression in non-obese diabetic (NOD) mice.
    Alam C; Bittoun E; Bhagwat D; Valkonen S; Saari A; Jaakkola U; Eerola E; Huovinen P; Hänninen A
    Diabetologia; 2011 Jun; 54(6):1398-406. PubMed ID: 21380595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic effect of CXCR3-expressing regulatory T cells on liver, lung and intestinal damages in a murine acute GVHD model.
    Hasegawa H; Inoue A; Kohno M; Lei J; Miyazaki T; Yoshie O; Nose M; Yasukawa M
    Gene Ther; 2008 Feb; 15(3):171-82. PubMed ID: 17989707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Singular role for T-BET+CXCR3+ regulatory T cells in protection from autoimmune diabetes.
    Tan TG; Mathis D; Benoist C
    Proc Natl Acad Sci U S A; 2016 Dec; 113(49):14103-14108. PubMed ID: 27872297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. tRNA-derived fragments in T lymphocyte-beta cell crosstalk and in type 1 diabetes pathogenesis in NOD mice.
    Brozzi F; Jacovetti C; Cosentino C; Menoud V; Wu K; Bayazit MB; Abdulkarim B; Iseli C; Guex N; Guay C; Regazzi R
    Diabetologia; 2024 Oct; 67(10):2260-2274. PubMed ID: 38967669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Novel Liposome Formulation Carrying Both an Insulin Peptide and a Ligand for Invariant Natural Killer T Cells Induces Accumulation of Regulatory T Cells to Islets in Nonobese Diabetic Mice.
    Akimoto H; Fukuda-Kawaguchi E; Duramad O; Ishii Y; Tanabe K
    J Diabetes Res; 2019; 2019():9430473. PubMed ID: 31781669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of aryl hydrocarbon receptor by TCDD prevents diabetes in NOD mice and increases Foxp3+ T cells in pancreatic lymph nodes.
    Kerkvliet NI; Steppan LB; Vorachek W; Oda S; Farrer D; Wong CP; Pham D; Mourich DV
    Immunotherapy; 2009 Jul; 1(4):539-47. PubMed ID: 20174617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccination with a co-expression DNA plasmid containing GAD65 fragment gene and IL-10 gene induces regulatory CD4(+) T cells that prevent experimental autoimmune diabetes.
    Liu X; Zhang S; Li X; Zheng P; Hu F; Zhou Z
    Diabetes Metab Res Rev; 2016 Sep; 32(6):522-33. PubMed ID: 26797873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting of IL-2 receptor with a caspase fusion protein disrupts autoimmunity in prediabetic and diabetic NOD mice.
    Yarkoni S; Kaminitz A; Sagiv Y; Askenasy N
    Diabetologia; 2010 Feb; 53(2):356-68. PubMed ID: 19946662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Foxp3-expressing CD4(+)T cells under the control of INF-gamma promoter prevent diabetes in NOD mice.
    Wang R; Han G; Wang J; Song L; Chen G; Xu R; Yu M; Qian J; Shen B; Li Y
    Mol Ther; 2007 Aug; 15(8):1551-7. PubMed ID: 17534268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes.
    Tritt M; Sgouroudis E; d'Hennezel E; Albanese A; Piccirillo CA
    Diabetes; 2008 Jan; 57(1):113-23. PubMed ID: 17928397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered homeostasis and development of regulatory T cell subsets represent an IL-2R-dependent risk for diabetes in NOD mice.
    Dwyer CJ; Bayer AL; Fotino C; Yu L; Cabello-Kindelan C; Ward NC; Toomer KH; Chen Z; Malek TR
    Sci Signal; 2017 Dec; 10(510):. PubMed ID: 29259102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice.
    Tarbell KV; Petit L; Zuo X; Toy P; Luo X; Mqadmi A; Yang H; Suthanthiran M; Mojsov S; Steinman RM
    J Exp Med; 2007 Jan; 204(1):191-201. PubMed ID: 17210729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of chemokines, CXC chemokine ligand 10 (CXCL10) and CXCR3 in the inflamed islets of patients with recent-onset autoimmune type 1 diabetes.
    Uno S; Imagawa A; Saisho K; Okita K; Iwahashi H; Hanafusa T; Shimomura I
    Endocr J; 2010; 57(11):991-6. PubMed ID: 20966598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic and functional data identifying Cd101 as a type 1 diabetes (T1D) susceptibility gene in nonobese diabetic (NOD) mice.
    Mattner J; Mohammed JP; Fusakio ME; Giessler C; Hackstein CP; Opoka R; Wrage M; Schey R; Clark J; Fraser HI; Rainbow DB; Wicker LS
    PLoS Genet; 2019 Jun; 15(6):e1008178. PubMed ID: 31199784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in T regulatory cells between mouse strains frequently used in immunological research: Treg cell quantities and subpopulations in NOD, B6 and BALB/c mice.
    Godoy GJ; Paira DA; Olivera C; Breser ML; Sanchez LR; Motrich RD; Rivero VE
    Immunol Lett; 2020 Jul; 223():17-25. PubMed ID: 32330480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined insulin B:9-23 self-peptide and polyinosinic-polycytidylic acid accelerate insulitis but inhibit development of diabetes by increasing the proportion of CD4+Foxp3+ regulatory T cells in the islets in non-obese diabetic mice.
    Fukushima K; Abiru N; Nagayama Y; Kobayashi M; Satoh T; Nakahara M; Kawasaki E; Yamasaki H; Ueha S; Matsushima K; Liu E; Eguchi K
    Biochem Biophys Res Commun; 2008 Mar; 367(4):719-24. PubMed ID: 18194666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancreatic β-Cell production of CXCR3 ligands precedes diabetes onset.
    Burke SJ; Karlstad MD; Eder AE; Regal KM; Lu D; Burk DH; Collier JJ
    Biofactors; 2016 Nov; 42(6):703-715. PubMed ID: 27325565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Small molecule CXCR3 antagonist NIBR2130 has only a limited impact on type 1 diabetes in a virus-induced mouse model.
    Christen S; Holdener M; Beerli C; Thoma G; Bayer M; Pfeilschifter JM; Hintermann E; Zerwes HG; Christen U
    Clin Exp Immunol; 2011 Sep; 165(3):318-28. PubMed ID: 21649647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural Protection From Type 1 Diabetes in NOD Mice Is Characterized by a Unique Pancreatic Islet Phenotype.
    Boldison J; Thayer TC; Davies J; Wong FS
    Diabetes; 2021 Apr; 70(4):955-965. PubMed ID: 33531355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.